Mentored Career Transition Award (KT1/R00)
Agency
National Institutes of Health
Posted
Aug 13, 2026
Due Date
Oct 12, 2027
Description
<p>The biphasic award will provide up to 5 years of support in two phases. The initial, mentored career development phase will provide 1-2 years of support for needed career development<i><strong> </strong></i>to facilitate a timely transition of promising postdoctoral researchers from their mentored postdoctoral research positions to independent, tenure-track or equivalent research-intensive faculty positions. The second phase will provide up to 3 years of independent research support, contingent on satisfactory progress during the first phase and an approved, independent, tenure-track (or equivalent) faculty position.</p>
AI Summary
Agency: National Institutes of Health
Details
- Notice ID
- 363569
- Solicitation Number
- PA-28-048
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health